Emergent BioSolutions Inc.
EBS · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $246 | $271 | $149 | $106 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $150 | $80 | $204 | $155 |
| Inventory | $356 | $339 | $314 | $312 |
| Other Curr. Assets | $36 | $30 | $40 | $27 |
| Total Curr. Assets | $787 | $720 | $707 | $599 |
| Property Plant & Equip (Net) | $210 | $224 | $221 | $282 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $453 | $469 | $485 | $502 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $7 |
| Other NC Assets | $12 | $5 | $13 | $7 |
| Total NC Assets | $674 | $698 | $719 | $798 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,461 | $1,417 | $1,426 | $1,397 |
| Liabilities | – | – | – | – |
| Payables | $57 | $64 | $58 | $61 |
| Short-Term Debt | $0 | $2 | $0 | $3 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $5 | $0 | $5 |
| Other Curr. Liab. | $79 | $25 | $41 | $38 |
| Total Curr. Liab. | $137 | $127 | $112 | $162 |
| LT Debt | $663 | $668 | $666 | $664 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $36 | $47 | $60 | $49 |
| Other NC Liab. | $43 | $33 | $35 | $29 |
| Total NC Liab. | $742 | $754 | $762 | $752 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $879 | $881 | $873 | $914 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$105 | -$156 | -$144 | -$212 |
| AOCI | -$8 | -$8 | -$6 | -$5 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $583 | $536 | $553 | $483 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1,461 | $1,417 | $1,426 | $1,397 |
| Net Debt | $418 | $399 | $517 | $561 |